Starpharma Holdings Ltd is an Australian biotechnology company that develops pharmaceutical and medical products based on its proprietary DEP(R) dendrimer nanotechnology platform. The platform is used to create enhanced drug delivery formulations that can improve solubility, targeting, and the overall safety and efficacy of therapeutics.
Melbourne
1996
11–50
